Hexaminolevulinate-induced Fluorescence versus White Light During Transurethral Resection of Noninvasive Bladder Tumor: Does It Reduce Recurrences?
Anticancer Hospital Agios Sabas, Athens, Greece. Urology
(Impact Factor: 2.19).
08/2012; 80(2):354-9. DOI: 10.1016/j.urology.2012.03.067
To evaluate the effect of hexaminolevulinate (HAL)-induced fluorescence during resection of noninvasive bladder cancer on tumor recurrence compared with resection under white light.
Between 2008 and 2010, 102 consecutive patients with suspected bladder cancer were randomized to undergo transurethral resection with either conventional white light or combination of white light and HAL-induced fluorescence. Difference in tumor recurrence rate and recurrence-free survival between the 2 groups was evaluated. Subgroup analysis on recurrence-free survival was performed for different tumor parameters.
Cystoscopy at 3 months revealed tumor recurrence in 6 of 45 (13.3%) patients of the white light group compared with only 1 of 41 patients of the HAL group (2.4%) (P < .001). The recurrence-free rates in white light patients at 12 and 18 months were 56.3% and 50.6%, respectively, compared with 91% and 82.5% in HAL patients (P = .0006). In subgroup analyses, recurrence-free survival was similar between the 2 groups when solitary tumors were treated (P = .3525). However, the HAL group had a favorable recurrence-free survival compared with the white light group when multifocal tumors (P < .001), primary tumors (P = .0237), recurrent tumors (P = .0189), nonaggressive (papillary urothelial neoplasm of low malignant potential and low grade) tumors (P = .0204), or aggressive (high grade and carcinoma in situ) tumors (P = .0134) were treated.
HAL significantly aids resection of non-muscle-invasive bladder cancer with the result of reduction in tumor recurrence rates.
Available from: Lindsay A. Hampson
- "5 St. John Hosp, Romania 1 NR HAL FL vs. WL cystoscopy: FL greater number of tumors detected and decreased recurrence rates (12 and 24 mo) Karaolides et al. (2012)  "
Urologic Oncology 08/2014; 32(6):735-40. DOI:10.1016/j.urolonc.2014.05.007 · 2.77 Impact Factor
Available from: Qiang Wei
- "We also found that differences in RFS rates between patients in the WLC group and those in the FC subgroups were not coinciding. Babjuk et al , Geavlete et al  and Karaolides et al  reported no statistically significant difference in RFS at 1 year between the FC and WLC groups when solitary tumours were treated (p = 0.74, 0.064 and 0.352, respectively); however, a statistically significant difference in RFS was observed between the FC and WLC groups when multifocal tumours were treated (p = 0.001, 0.001 and <0.001, respectively). The superiority of FC was particularly obvious in the intermediate-risk (p = 0.02) and high-risk (p = 0.05) groups, but this advantage did not achieve statistical significance in the low-risk group (p = 0.25) . "
[Show abstract] [Hide abstract]
ABSTRACT: To conduct a meta-analysis of randomized controlled trials (RCTs) to assess the therapeutic outcome of fluorescence cystoscopy (FC) guided transurethral resection (TUR) in non-muscle invasive bladder cancer (NMIBC).
Relevant RCTs were identified from electronic database (MEDLINE, Embase and the Cochrane Library). The proceedings of relevant congress were also searched. The primary parameters were recurrence rate, the time to fist recurrence, recurrence free survival rate (RFS) and progression rate.
12 RCTs including 2258 patients, which were identified for analysis in our study. Our study showed that the FC group have lower recurrence rate than the white light cystoscopy (WLC) group with statistically significant difference (OR: 0.5; p<0.00001). The time of the FC group first recurrence delayed significantly 7.39 weeks than WLC group (MD: 7.39 weeks; p<0.0001). There was a statistically significant difference in favor of FC in RFS at 1 yr (HR: 0.69; p<0.00001) and 2 yrs (HR: 0.65; p=0.0004). However, the FC group cannot significantly reduce the rate of progression into muscle invasive bladder cancer compared with the WLC group (OR: 0.85; p=0.39).
FC guided TUR was demonstrated to be an effective procedure for delaying recurrence of NMIBC. Unfortunately, FC guided TUR could not significantly decrease the rate of progression into muscle invasive bladder cancer.
PLoS ONE 09/2013; 8(9):e74142. DOI:10.1371/journal.pone.0074142 · 3.23 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: The diagnosis and follow-up of bladder cancer is based on the so-called golden standard of urine cytology and white light endoscopy. In recent years fluorescence endoscopy, also known as photodynamic diagnosis (PDD), of the urinary bladder has become more and more popular. The rising interest in this procedure becomes clear when looking at the current literature. Nowadays, there are studies on PDD from all over Europe and the USA. This article gives an up to date review of these new studies and shows new developments in the outpatient use of PDD.
Der Urologe 03/2013; · 0.44 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.